24-Hr MQoLQ Instrument Proves Effective in Assessing Migraine Burden
“Migraine attacks can be severely burdensome, intensely painful, and debilitating, often...
Migraine
Novel synthetic treatment options for migraine.
: Migraine is one of the most common neurological disorders. Nowadays, the 5-HT receptor agonists, namely triptans, are considered as the standard of care for migraine acute treatment. However, triptans have limitations in some...
Muscle Fascia Changes in Patients with Occipital Neuralgia, Headache, or Migraine.
In an ongoing effort to understand the pathogenesis of occipital neuralgia/headache/migraine, it is critical to describe the anatomical/tissue changes encountered during surgery. Greater occipital nerve anatomical studies mainly...
Orthostatic Headache in Children Including Postural Tachycardia Syndrome and Orthostatic Hypotension: A Near-Infrared Spectroscopy Study.
Although head and/or neck pain attributed to orthostatic hypotension is included in international guidelines, its mechanisms and relevance remain unknown. This study examined the term’s relevance and aimed to elucidate the...
Workplace Migraine Management Program Benefits Employees & Employers
“Despite being such a prevalent disease, with 1 person in 7 being affected, migraine is vastly...
Effect of migraine attack on pupil size, accommodation and ocular aberrations.
To evaluate the pupil size, accommodation, and ocular higher-order aberrations (HOAs) in patients with migraine during migraine attacks and compare them with interictal period and healthy controls.This prospective, case-control...
Super-Utilization of the Emergency Department in a Universally Insured Population.
Super-utilizers (patients with 4 or more emergency department [ED] visits a year) account for 10% to 26% of all ED visits and are responsible for a growing proportion of healthcare expenditures. Patients recognize the ED as a...
Equity of African American Men in Headache in the United States: A Perspective From African American Headache Medicine Specialists (Part 1).
Migraine and severe headache affect approximately 1 in 6 U.S. adults and migraine is one of the most disabling disorders worldwide. Approximately 903,000 to 1.5 million African American (AA) men are affected by migraine in the...
Equity of African American Men in Headache in the United States: A Perspective From African American Headache Medicine Specialists (Part 2).
In part 1 of this opinion piece, we described inherent and potential challenges of the equity of African American (AA) men in headache medicine including headache disparities, mistrust, understudied/lack of representation in...
Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN).
To evaluate secondary outcomes including changes in functioning and disability associated with galcanezumab, a humanized monoclonal antibody to calcitonin gene-related peptide, in patients with chronic migraine.Patients randomly...
CME: Comorbidities & Risk of Migraine Progression
This course discusses a study that sought to test the hypothesis that subgroups of migraine...
Acupuncture versus Various Control Treatments in the Treatment of Migraine: A Review of Randomized Controlled Trials from the Past 10 Years.
Migraine is defined as a recurrent headache of moderate to severe intensity that seriously affects the quality of life. Recent clinical trials have confirmed that acupuncture is effective in treating migraine. We aimed to review...
